tiprankstipranks
Advertisement
Advertisement

JP:4503 Stock Latest News

Astellas Books Major Impairment and Extraordinary Losses in FY2025 Non-Consolidated Results
Company AnnouncementsAstellas Books Major Impairment and Extraordinary Losses in FY2025 Non-Consolidated Results
6d ago
Astellas Pharma Announces New Board Slate and Governance Changes for 2026
PremiumCompany Announcements
Astellas Pharma Announces New Board Slate and Governance Changes for 2026
6d ago
Is ALPMF a Buy, Before Earnings?
PremiumPre-Earnings
Is ALPMF a Buy, Before Earnings?
8d ago
Astellas Highlights R&D Strategy While Flagging Market and Development Risks
PremiumCompany Announcements
Astellas Highlights R&D Strategy While Flagging Market and Development Risks
1M ago
Astellas and HOVON Phase 3 AML Trial for Xospata Misses Survival Goal
PremiumCompany Announcements
Astellas and HOVON Phase 3 AML Trial for Xospata Misses Survival Goal
2M ago
Astellas Flags Risks and Uncertainties Around Sustainability Plans and Pipeline
PremiumCompany AnnouncementsAstellas Flags Risks and Uncertainties Around Sustainability Plans and Pipeline
2M ago
Astellas Settles Myrbetriq Patent Disputes with Lupin and Zydus
Premium
Company Announcements
Astellas Settles Myrbetriq Patent Disputes with Lupin and Zydus
3M ago
Solid Near-Term Outperformance but Post-Xtandi Uncertainty Keeps Shares at Hold
Premium
Ratings
Solid Near-Term Outperformance but Post-Xtandi Uncertainty Keeps Shares at Hold
3M ago
Astellas Lifts FY2025 Outlook on Robust XTANDI and Mirabegron Demand
PremiumCompany Announcements
Astellas Lifts FY2025 Outlook on Robust XTANDI and Mirabegron Demand
3M ago
ALPMF Upcoming Earnings Report: What to Expect?
PremiumPre-Earnings
ALPMF Upcoming Earnings Report: What to Expect?
3M ago
Astellas and Pfizer Unveil Breakthrough in Bladder Cancer Treatment
PremiumCompany Announcements
Astellas and Pfizer Unveil Breakthrough in Bladder Cancer Treatment
5M ago
Astellas Pharma Revises FY2025 Financial Forecasts Upward
PremiumCompany Announcements
Astellas Pharma Revises FY2025 Financial Forecasts Upward
6M ago
Astellas Pharma (ALPMF) Q2 Earnings Cheat Sheet
PremiumPre-EarningsAstellas Pharma (ALPMF) Q2 Earnings Cheat Sheet
6M ago
Astellas Pharma’s GLEAM Trial Falls Short of Primary Endpoint in Pancreatic Cancer Study
Premium
Company Announcements
Astellas Pharma’s GLEAM Trial Falls Short of Primary Endpoint in Pancreatic Cancer Study
7M ago
Astellas Pharma’s IZERVAY Gains Conditional Approval in Japan for Geographic Atrophy
Premium
Company Announcements
Astellas Pharma’s IZERVAY Gains Conditional Approval in Japan for Geographic Atrophy
8M ago
Astellas Pharma: Hold Rating Amid Growth Challenges and Product Limitations
PremiumRatings
Astellas Pharma: Hold Rating Amid Growth Challenges and Product Limitations
8M ago
Pfizer and Astellas Announce Breakthrough in Bladder Cancer Treatment
PremiumCompany Announcements
Pfizer and Astellas Announce Breakthrough in Bladder Cancer Treatment
9M ago
Astellas Reports Strong Preliminary Sales for IZERVAY™ in Q1 FY2025
PremiumCompany Announcements
Astellas Reports Strong Preliminary Sales for IZERVAY™ in Q1 FY2025
10M ago
Astellas Pharma Continues Performance-linked Stock Schemes for Executives
PremiumCompany Announcements
Astellas Pharma Continues Performance-linked Stock Schemes for Executives
12M ago
Astellas Pharma Continues Performance-linked Stock Compensation Scheme for 2025
PremiumCompany AnnouncementsAstellas Pharma Continues Performance-linked Stock Compensation Scheme for 2025
12M ago
Astellas Pharma Announces Changes to Board of Directors
Premium
Company Announcements
Astellas Pharma Announces Changes to Board of Directors
12M ago
Astellas Pharma Reports Record Revenue and Growth
Premium
Company Announcements
Astellas Pharma Reports Record Revenue and Growth
1y ago

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >